Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,724,150
  • Shares Outstanding, K 218,479
  • Annual Sales, $ 872,000 K
  • Annual Income, $ -23,550 K
  • EBIT $ 43 M
  • EBITDA $ 47 M
  • 60-Month Beta 1.25
  • Price/Sales 6.60
  • Price/Cash Flow N/A
  • Price/Book 13.05

Options Overview Details

View History
  • Implied Volatility 88.73% ( -7.95%)
  • Historical Volatility 143.53%
  • IV Percentile 67%
  • IV Rank 51.35%
  • IV High 129.37% on 08/05/24
  • IV Low 45.83% on 12/21/23
  • Put/Call Vol Ratio 0.68
  • Today's Volume 59,782
  • Volume Avg (30-Day) 81,510
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 651,775
  • Open Int (30-Day) 589,400

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.12
  • Number of Estimates 8
  • High Estimate 0.16
  • Low Estimate 0.09
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +1,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.36 +22.66%
on 11/21/24
35.02 -25.19%
on 11/27/24
+4.41 (+20.24%)
since 11/20/24
3-Month
16.05 +63.24%
on 10/03/24
35.02 -25.19%
on 11/27/24
+9.90 (+60.74%)
since 09/20/24
52-Week
8.09 +223.86%
on 01/05/24
35.02 -25.19%
on 11/27/24
+17.86 (+214.15%)
since 12/20/23

Most Recent Stories

More News
Hims & Hers Stock: Growth, Noise, and Where to Focus Now

Hims & Hers stock is full of noise, but what's the signal for investors?

HIMS : 26.20 (-0.61%)
This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

NVO : 85.00 (-17.83%)
HIMS : 26.20 (-0.61%)
LLY : 767.76 (+1.35%)
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further?

Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust growth in 2024. Shares of the company have risen 43% in the past month, significantly...

LFMD : 5.04 (+2.86%)
TDOC : 9.44 (+5.24%)
HIMS : 26.20 (-0.61%)
AMWL : 7.87 (+0.38%)
Wall Street Sounds Alarm On Hims & Hers Amid Ro-Eli Lilly Zepbound Tie-Up: Retail Shrugs It Off

Leerink analysts said the Ro-Lilly partnership is likely to cause volatility for Hims & Hers shares.

HIMS : 26.20 (-0.61%)
LLY : 767.76 (+1.35%)
4 Stocks That Crushed Analyst Estimates by More Than Double

Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.

AA : 37.84 (+3.33%)
NVDA : 134.70 (+3.08%)
HIMS : 26.20 (-0.61%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
LRN : 105.21 (-0.82%)
VICR : 49.17 (+0.18%)
MPWR : 593.22 (+0.69%)
Amazon’s Healthcare Gamble: A New Era of Medical Disruption

Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics.

HIMS : 26.20 (-0.61%)
AMZN : 224.92 (+0.73%)
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick

Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.

TDOC : 9.44 (+5.24%)
HIMS : 26.20 (-0.61%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
Teladoc Stock Rises 59.4% in Three Months: Is This Your Buy Signal?

Teladoc Health, Inc. TDOC shares have returned 59.4% in the past three months, outperforming the industry and the S&P 500 Index. Over this timeframe, the industry and the S&P 500 Index have declined 11.7%...

TDOC : 9.44 (+5.24%)
HIMS : 26.20 (-0.61%)
AMWL : 7.87 (+0.38%)
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch

Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.

AZN : 65.35 (+1.41%)
HIMS : 26.20 (-0.61%)
LLY : 767.76 (+1.35%)
PFE : 26.36 (+2.29%)
Why Hims & Hers Stock Jumped on Massive FDA News

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

HIMS : 26.20 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 28.94
2nd Resistance Point 28.03
1st Resistance Point 27.12
Last Price 26.20
1st Support Level 25.30
2nd Support Level 24.39
3rd Support Level 23.48

See More

52-Week High 35.02
Last Price 26.20
Fibonacci 61.8% 24.73
Fibonacci 50% 21.56
Fibonacci 38.2% 18.38
52-Week Low 8.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar